10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-124403`
Period End Date	20200930
Filing Date	20201112
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	bpth-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 36 Cash Flow Statement 41 Stockholders Equity 23

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$20.43M	USD	Point-in-time
Cash	`Cash`	$12.06M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$776.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$980.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.28M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$788.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.99M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.31M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	3.69M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	3.69M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	3.69M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.03M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	3.69M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.03M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$726.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$780.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$303.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$249.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$367.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$309.00K	USD	Point-in-time
Total Assets	`Assets`	$14.87M	USD	Point-in-time
Total Assets	`Assets`	$22.66M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$614.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$486.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$721.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$673.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$92.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$85.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.24M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.43M	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$330.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$260.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.69M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.57M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 3,692 and 3,692 shares issued and outstanding, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 3,692 and 3,692 shares issued and outstanding, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$77.85M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$77.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-56.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-64.67M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.22M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.02M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$17.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.01M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$21.09M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$13.19M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$22.66M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$14.87M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.30M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.04M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.38M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$970.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.98M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.32M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$896.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.36M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.97M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.28M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.27M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.28M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.27M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.97M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-8.36M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$29.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$25.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$70.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$29.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$70.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$25.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.21M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.24M	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-2.26	USD	3 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-0.78	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-2.51	USD	3 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-0.80	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.87M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.69M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.69M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.47M	shares	3 Qtrs

Cash Flow Statement 41 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.21M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.24M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$522.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$432.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$58.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$75.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$116.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$54.00K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$433.00K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$204.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-64.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$489.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-187.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$176.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$63.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$63.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.12M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.37M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$17.00M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$900.00K	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.50M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.41M	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$1.08M	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.49M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-8.37M	USD	3 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.38M	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.38M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.06M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.43M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.38M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.06M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.43M	USD	Point-in-time
Non-cash leasehold improvements	`NonCashLeaseholdImprovements`	$-31.00K	USD	3 Qtrs
Non-cash leasehold improvements	`NonCashLeaseholdImprovements`	-	USD	3 Qtrs

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$16.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$16.01M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$21.09M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$13.19M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$19.41M	USD	3 Qtrs
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$1.08M	USD	3 Qtrs
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$169.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$184.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$432.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$522.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$143.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.21M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.24M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$16.02M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$16.01M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$21.09M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$13.19M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.